Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company operates through two primary segments: the United States and International.
Founded in 1952 as a division of Pfizer, Zoetis became an independent company in 2013. It's headquartered in Parsippany, New Jersey, United States.
Main Product(s):
Zoetis specializes in the production of a wide range of veterinary vaccines and medicines, including anti-infectives, vaccines, parasite control, and pain management drugs.
Short History of Zoetis Inc:
1952 – Zoetis was established as a division of Pfizer.
February 2013 – Zoetis completed its initial public offering (IPO), becoming a fully independent company.
2015 – The company expanded its product portfolio with the acquisition of Pharmaq, a global leader in vaccines for aquaculture.
2020 – Zoetis acquired Performance Livestock Analytics to enhance its digital and data analytics capabilities in livestock.
Key Executives:
Name
Title
Pay
Exercised
Year Born
Ms. Kristin C. Peck
CEO & Director
2.8M
3.05M
1971
Mr. Wetteny N. Joseph
Executive VP & CFO
1.26M
N/A
1972
Ms. Wafaa Mamilli
EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health
1.08M
N/A
1967
Ms. Heidi C. Chen
Executive VP, General Counsel, Corporate Secretary & Business Lead of Human Health Diagnostics
1.04M
N/A
1967
Ms. Roxanne Lagano
Executive VP and Chief Human Resources Officer & Global Operations
N/A
N/A
1965
Mr. Steven Frank
Vice President of Investor Relations
N/A
N/A
N/A
Mr. William Price
VP & Chief Communications Officer
N/A
N/A
N/A
Dr. Robert J. Polzer Ph.D.
Executive VP and President of Research & Development
N/A
N/A
1969
Ms. Jeannette Ferran Astorga
Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer
N/A
N/A
1975
Mr. Nick Ashton
Executive VP and President of Global Manufacturing & Supply